Dilwali Sonam, Patel Pratik B, Roberts Daniel S, Basinsky Gina M, Harris Gordon J, Emerick Kevin S, Stankovic Konstantina M
Speech and Hearing Bioscience and Technology Program, Harvard - Massachusetts Institute of Technology, Division of Health Sciences and Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA; Eaton Peabody Laboratories and Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA, 02114, USA.
Department of Otology and Laryngology, Harvard Medical School, 651 Huntington Avenue, Boston, MA 02115, USA; Eaton Peabody Laboratories and Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA, 02114, USA.
Hear Res. 2014 Sep;315:25-33. doi: 10.1016/j.heares.2014.05.006. Epub 2014 Jun 6.
Primary culture of human Schwann cells (SCs) and vestibular schwannoma (VS) cells are invaluable tools to investigate SC physiology and VS pathobiology, and to devise effective pharmacotherapies against VS, which are sorely needed. However, existing culture protocols, in aiming to create robust, pure cultures, employ methods that can lead to loss of biological characteristics of the original cells, potentially resulting in misleading biological findings. We have developed a minimally manipulative method to culture primary human SC and VS cells, without the use of selective mitogens, toxins, or time-consuming and potentially transformative laboratory techniques. Schwann cell purity was quantified longitudinally using S100 staining in SC cultures derived from the great auricular nerve and VS cultures followed for 7 and 12 weeks, respectively. SC cultures retained approximately ≥85% purity for 2 weeks. VS cultures retained approximately ≥80% purity for the majority of the span of 12 weeks, with maximal purity of 87% at 2 weeks. The VS cultures showed high level of biological similarity (68% on average) to their respective parent tumors, as assessed using a protein array featuring 41 growth factors and receptors. Apoptosis rate in vitro negatively correlated with tumor volume. Our results, obtained using a faster, simplified culturing method than previously utilized, indicate that highly pure, primary human SC and VS cultures can be established with minimal manipulation, reaching maximal purity at 2 weeks of culture. The VS cultures recapitulate the parent tumors' biology to a great degree, making them relevant models to investigate VS pathobiology.
人雪旺细胞(SCs)和前庭神经鞘瘤(VS)细胞的原代培养是研究雪旺细胞生理学和前庭神经鞘瘤病理生物学以及设计针对前庭神经鞘瘤的有效药物疗法的宝贵工具,而这些疗法是非常急需的。然而,现有的培养方案为了创建强大、纯净的培养物,采用的方法可能会导致原始细胞生物学特性的丧失,从而可能产生误导性的生物学研究结果。我们开发了一种微创操作方法来培养原代人雪旺细胞和前庭神经鞘瘤细胞,无需使用选择性促细胞分裂剂、毒素或耗时且可能具有转化作用的实验室技术。分别在源自耳大神经的雪旺细胞培养物以及培养7周和12周的前庭神经鞘瘤细胞培养物中,使用S100染色纵向定量雪旺细胞纯度。雪旺细胞培养物在2周内保持约≥85%的纯度。前庭神经鞘瘤细胞培养物在12周的大部分时间内保持约≥80%的纯度,在2周时纯度最高可达87%。使用包含41种生长因子和受体的蛋白质阵列评估,前庭神经鞘瘤细胞培养物与其各自的亲本肿瘤表现出高度的生物学相似性(平均68%)。体外凋亡率与肿瘤体积呈负相关。我们使用比以前更快、更简化的培养方法获得的结果表明,通过最少的操作就可以建立高度纯净的原代人雪旺细胞和前庭神经鞘瘤细胞培养物,在培养2周时达到最大纯度。前庭神经鞘瘤细胞培养物在很大程度上重现了亲本肿瘤的生物学特性,使其成为研究前庭神经鞘瘤病理生物学的相关模型。